semaglutide 2.4 mg obesity 50 of oral #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Adults with overweight or obesity

Its often used in clinical settings for targeted fat loss

Atvb 39 (6), 10451054

The injection angle and hold time vary by product

If GLP-1 patches were viable, Dr

However, some individuals reported negative effects as well

Odds of ischaemic optic neuropathy nearly 5 times higher than among users of Ozempic And 3 times higher in men than in women, analysis of unintended side effect reports shows Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of eye stroke (ischaemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published in the British Journal of Ophthalmology